Please Wait
Applying Filters...
menu
    • menu

    Annual Sales of NCGC00024995-05 reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

    Client Email Product
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Sarv BioLabs Paclitaxel

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    NCGC00024995-05

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 23,728Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 15Abraxane

    02 3Abraxane

    03 1Abraxane - BMS

    04 1Abraxane - Celgene

    PharmaCompass
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Abraxane

    Paclitaxel Protein Bound

    arrow
    AAPS 2024
    Not Confirmed

    Brand Name : Abraxane

    U.S.A
    arrow
    AAPS 2024
    Not Confirmed

    Bristol Myers Squibb

    Paclitaxel Protein Bound

    Main Therapeutic Indication : Oncology

    Currency : USD

    2020 Revenue in Millions : 1,247

    2019 Revenue in Millions : 1,086

    Growth (%) : 15

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Abraxane

    Paclitaxel protein bound)

    arrow
    AAPS 2024
    Not Confirmed

    Brand Name : Abraxane

    China
    arrow
    AAPS 2024
    Not Confirmed

    Beigene

    Paclitaxel protein bound)

    Main Therapeutic Indication : Oncology

    Currency : USD

    2021 Revenue in Millions : 0

    2020 Revenue in Millions : 19

    Growth (%) : -100

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Abraxane

    Paclitaxel Protein Bound

    arrow
    AAPS 2024
    Not Confirmed

    Brand Name : Abraxane

    Japan
    arrow
    AAPS 2024
    Not Confirmed

    Otsuka

    Paclitaxel Protein Bound

    Main Therapeutic Indication : Oncology

    Currency : USD

    2020 Revenue in Millions : 292

    2019 Revenue in Millions : 275

    Growth (%) : 6

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Abraxane

    Paclitaxel Protein Bound

    arrow
    AAPS 2024
    Not Confirmed

    Brand Name : Abraxane

    U.S.A
    arrow
    AAPS 2024
    Not Confirmed

    Bristol Myers Squibb

    Paclitaxel Protein Bound

    Main Therapeutic Indication : Oncology

    Currency : USD

    2021 Revenue in Millions : 1,181

    2020 Revenue in Millions : 1,247

    Growth (%) : -5

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Abraxane

    Paclitaxel Protein Bound

    arrow
    AAPS 2024
    Not Confirmed

    Brand Name : Abraxane

    Japan
    arrow
    AAPS 2024
    Not Confirmed

    Otsuka

    Paclitaxel Protein Bound

    Main Therapeutic Indication : Oncology

    Currency : USD

    2021 Revenue in Millions : 242

    2020 Revenue in Millions : 280

    Growth (%) : -7

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Abraxane

    Paclitaxel Protein Bound

    arrow
    AAPS 2024
    Not Confirmed

    Brand Name : Abraxane

    U.S.A
    arrow
    AAPS 2024
    Not Confirmed

    Bristol Myers Squibb

    Paclitaxel Protein Bound

    Main Therapeutic Indication : Oncology

    Currency : USD

    2022 Revenue in Millions : 811

    2021 Revenue in Millions : 1,181

    Growth (%) : -31

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : Abraxane

    Paclitaxel Protein Bound

    arrow
    AAPS 2024
    Not Confirmed

    Brand Name : Abraxane

    Japan
    arrow
    AAPS 2024
    Not Confirmed

    Otsuka

    Paclitaxel Protein Bound

    Main Therapeutic Indication : Oncology

    Currency : USD

    2022 Revenue in Millions : 153

    2021 Revenue in Millions : 242

    Growth (%) : -37

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Brand Name : Abraxane

    Paclitaxel Protein Bound

    arrow
    AAPS 2024
    Not Confirmed

    Brand Name : Abraxane

    U.S.A
    arrow
    AAPS 2024
    Not Confirmed

    Bristol Myers Squibb

    Paclitaxel Protein Bound

    Main Therapeutic Indication : Oncology

    Currency : USD

    2023 Revenue in Millions : 1,004

    2022 Revenue in Millions : 811

    Growth (%) : 24

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Brand Name : Abraxane

    Paclitaxel Protein Bound

    arrow
    AAPS 2024
    Not Confirmed

    Brand Name : Abraxane

    Japan
    arrow
    AAPS 2024
    Not Confirmed

    Otsuka

    Paclitaxel Protein Bound

    Main Therapeutic Indication : Oncology

    Currency : USD

    2023 Revenue in Millions : 213

    2022 Revenue in Millions : 153

    Growth (%) : 58

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Brand Name : Abraxane

    Paclitaxel protein-bound

    arrow
    AAPS 2024
    Not Confirmed

    Brand Name : Abraxane

    U.S.A
    arrow
    AAPS 2024
    Not Confirmed

    Celgene Corpoartion

    Paclitaxel protein-bound

    Main Therapeutic Indication : Oncology

    Currency : USD

    2015 Revenue in Millions : 848

    2014 Revenue in Millions : 968

    Growth (%) : 14%

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF